Assyro AI

Orange Book product · Brand (NDA)

TAUVID

FLORTAUCIPIR F-18

Brand (NDA)NDA 212123DISCN AVID RADIOPHARMS INC

At a glance

May 28, 2020

Approved

Brand (NDA)

Application

Not listed

TE code

1

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    May 28, 2020

    6 yr 2 mo ago

  2. Today

  3. Patent 8932557 expires

    Listed drug substance patent expiration.

    May 26, 2032

    in 6 yr

Pharmaceutical detail

Active ingredient

FLORTAUCIPIR F-18

Strength

30ML (8.1-51mCi/ML)

Dosage form

SOLUTION

Route

INTRAVENOUS

TE code

Not listed

Application

NDA 212123

Product number

001

Marketing status

DISCN

Reference listed drug (RLD)

Yes

Reference standard (RS)

No

Active-ingredient family

View full family

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Listed patents (1)

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
PatentExpiresInType
8932557May 26, 2032in 6 yr
Substance
Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.